المؤلفون: Simone Brokamp, Annegien Broeks, Christian U. Blank, Petra Herzig, Marlous van den Braber, Daniela S. Thommen, Alfred Zippelius, Marjolein de Bruijn, Joyce Sanders, Ton N. Schumacher, Lisanne M. Roelofsen, Koen J. Hartemink, John B. A. G. Haanen, Kim Monkhorst, Paula Voabil, Sanne H. Hendriks

المصدر: Nature Medicine. 27:1250-1261

مصطلحات موضوعية: business.industry, medicine.medical_treatment, Cell, Cancer, General Medicine, Immunotherapy, medicine.disease, General Biochemistry, Genetics and Molecular Biology, Blockade, medicine.anatomical_structure, Immune system, Cell culture, medicine, Cancer research, Pd 1 blockade, business, Ex vivo

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::c45c19b51a9c099f12311a77da46c458Test
https://doi.org/10.1038/s41591-021-01398-3Test

المؤلفون: Christian U. Blank, Rodabe N. Amaria, Jennifer A. Wargo, Bart A. van de Wiel, Georgina V. Long, Hussein Abdul-Hassan Tawbi, Alexander C. Huang, Xiaowei Xu, Richard A. Scolyer, Tara C. Mitchell, Giorgos C. Karakousis, Alexander C.J. van Akkooi, Michael A. Davies, Andrew J. Spillane, Elisa A. Rozeman, Alexander M. Menzies, Robyn P. M. Saw, Michael T. Tetzlaff, Ahmad A. Tarhini, Thomas E. Pennington, Elizabeth M. Burton, Paolo A. Ascierto, Serigne Lo

المصدر: Nature Medicine. 27:301-309

مصطلحات موضوعية: 0301 basic medicine, Oncology, medicine.medical_specialty, business.industry, Surrogate endpoint, Melanoma, medicine.medical_treatment, Ipilimumab, General Medicine, Immunotherapy, medicine.disease, General Biochemistry, Genetics and Molecular Biology, Targeted therapy, Clinical trial, 03 medical and health sciences, 030104 developmental biology, 0302 clinical medicine, 030220 oncology & carcinogenesis, Internal medicine, Medicine, Nivolumab, business, Neoadjuvant therapy, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::826ffd3ff8235e1e6c027f5367069a0cTest
https://doi.org/10.1038/s41591-020-01188-3Test

المؤلفون: Christian U. Blank, Ton N. Schumacher, Hugo M. Horlings, Petur Snaebjornsson, Myriam Chalabi, Sabine C. Linn, Marleen Kok, Jolanda M. van Dieren

المصدر: JCO precision oncology. 1

مصطلحات موضوعية: Oncology, Cancer Research, medicine.medical_specialty, 030219 obstetrics & reproductive medicine, business.industry, medicine.medical_treatment, Immunotherapy, medicine.disease, 03 medical and health sciences, 0302 clinical medicine, Breast cancer, 030220 oncology & carcinogenesis, Internal medicine, medicine, DNA mismatch repair, business

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c1afb5805865cf876404be88ea57f57cTest
https://pubmed.ncbi.nlm.nih.gov/35172513Test

المؤلفون: Maurits L. van Montfoort, Daniel J. Vis, Kees Hendricksen, Nick van Dijk, Laura A. Smit, Michiel S. van der Heijden, Henk G. van der Poel, Maries van den Broek, Christian U. Blank, Annemarie Bruining, Yoni Lubeck, Lodewyk F. A. Wessels, Dennis Peters, Pia Kvistborg, Karina Silina, Ton N. Schumacher, Charlotte van Rooijen, Karolina Sikorska, Erik Hooijberg, Annegien Broeks, Bas W.G. van Rhijn, Alberto Gil-Jimenez, Jeantine M de Feijter, Thierry N. Boellaard

المساهمون: University of Zurich, van der Heijden, Michiel S, Graduate School

المصدر: Nature medicine, 26(12), 1839-1844. Nature Publishing Group

مصطلحات موضوعية: Adult, Male, 0301 basic medicine, medicine.medical_specialty, medicine.medical_treatment, Programmed Cell Death 1 Receptor, 610 Medicine & health, Ipilimumab, 10263 Institute of Experimental Immunology, Gastroenterology, General Biochemistry, Genetics and Molecular Biology, 03 medical and health sciences, Antineoplastic Agents, Immunological, 0302 clinical medicine, 1300 General Biochemistry, Genetics and Molecular Biology, Neoplasms, Internal medicine, Antineoplastic Combined Chemotherapy Protocols, Clinical endpoint, Humans, Medicine, CTLA-4 Antigen, Stage (cooking), Adverse effect, Aged, Neoplasm Staging, business.industry, Antibodies, Monoclonal, General Medicine, Immunotherapy, Middle Aged, Clinical trial, Nivolumab, 030104 developmental biology, 030220 oncology & carcinogenesis, Monoclonal, 570 Life sciences, biology, Female, Urothelium, business, medicine.drug

وصف الملف: 2020_van_Dijk_Nat_Med.pdf - application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0413d513e2c90df2d190163c39a4236dTest
http://www.scopus.com/inward/record.url?scp=85092396181&partnerID=8YFLogxKTest

المؤلفون: Christian U. Blank, Roger S. Lo, Magdalena Thurin, Claus Garbe, Sanjiv S. Agarwala, Sandra Demaria, Iman Osman, Richard D. Carvajal, Ryan J. Sullivan, Thomas F. Gajewski, Giorgio Trinchieri, Hassane M. Zarour, Georgina V. Long, Marc S. Ernstoff, Igor Puzanov, Paolo A. Ascierto, Jason J. Luke, Reinhard Dummer, Michael A. Postow, Corrado Caracò, Bernard A. Fox, Soldano Ferrone, Janis M. Taube, Patrick Hwu

المصدر: Journal of Translational Medicine, Vol 18, Iss 1, Pp 1-22 (2020)
Journal of Translational Medicine

مصطلحات موضوعية: BRAF inhibitor, 0301 basic medicine, Oncology, medicine.medical_specialty, Electrochemotherapy, medicine.medical_treatment, lcsh:Medicine, Meeting Report, Anti-CTLA-4, Target therapy, General Biochemistry, Genetics and Molecular Biology, 03 medical and health sciences, 0302 clinical medicine, Internal medicine, Tumor Microenvironment, medicine, Adjuvant therapy, Humans, CTLA-4 Antigen, Melanoma, Adjuvant, Combination strategies, MEK inhibitor, Tumor microenvironment, business.industry, lcsh:R, General Medicine, Immunotherapy, medicine.disease, Combined Modality Therapy, Anti-PD-1, CAR-T, Radiation therapy, 030104 developmental biology, Italy, 030220 oncology & carcinogenesis, Neoadjuvant, business, Biomarkers

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::262f60d640e699b9c9d97a5cc4583ea7Test
http://link.springer.com/article/10.1186/s12967-020-02482-xTest

المؤلفون: Michael Millward, V. Atkinson, Sandip Pravin Patel, Christoph Hoeller, Christian U. Blank, Andrew Haydon, Alexander N. Shoushtari, Reinhard Dummer, Alexander M. Menzies, James Larkin, Carina N. Owen, Arissa Young, Maartje W. Rohaan, Dharmisha Chauhan, Shahneen Sandhu, Douglas B. Johnson, J. Mangana, Georgina V. Long, D. Palmieri, Matteo S. Carlino, Serigne Lo, Muhammad A. Khattak, Farzana Y Zaman, Peter Hersey, Belinda Lee

المصدر: Ann Oncol

مصطلحات موضوعية: 0301 basic medicine, medicine.medical_specialty, Skin Neoplasms, medicine.medical_treatment, Ipilimumab, Gastroenterology, Article, 03 medical and health sciences, 0302 clinical medicine, Internal medicine, medicine, Adjuvant therapy, Humans, Stage (cooking), Melanoma, Hematology, business.industry, Mucosal melanoma, medicine.disease, Combined Modality Therapy, 030104 developmental biology, Oncology, 030220 oncology & carcinogenesis, Cutaneous melanoma, Immunotherapy, business, Adjuvant, medicine.drug

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4b83e339b674f679f965aaea6b9ddf88Test
https://doi.org/10.1016/j.annonc.2020.04.471Test

المؤلفون: Rutger H. T. Koornstra, Sandrine Marreaud, Victoria Atkinson, Andrey Meshcheryakov, Christian U. Blank, Piotr Rutkowski, Jean-Jacques Grob, Leonel Hernandez-Aya, Clemens Krepler, Michal Kicinski, Dirk Schadendorf, Paolo A. Ascierto, Caroline Robert, Mario Mandalà, Susana Puig, Nageatte Ibrahim, Alexander C.J. van Akkooi, Adnan Khattak, Stéphane Dalle, Georgina V. Long, James Larkin, Shahneen Sandhu, Rahima Jamal, Matteo S. Carlino, Alfonsus J M van den Eertwegh, Ralf Gutzmer, Anna Maria Di Giacomo, Andrew Haydon, Alexander M.M. Eggermont, Stefan Suciu, Paul Lorigan

المساهمون: CCA - Cancer Treatment and quality of life, Medical oncology

المصدر: Journal of Clinical Oncology, 38, 3925-3936
Eggermont, A M M, Blank, C U, Mandala, M, Long, G V, Atkinson, V G, Dalle, S, Haydon, A M, Meshcheryakov, A, Khattak, A, Carlino, M S, Sandhu, S, Larkin, J, Puig, S, Ascierto, P A, Rutkowski, P, Schadendorf, D, Koornstra, R, Hernandez-Aya, L, di Giacomo, A M, van den Eertwegh, A J M, Grob, J-J, Gutzmer, R, Jamal, R, Lorigan, P C, van Akkooi, A C J, Krepler, C, Ibrahim, N, Marreaud, S, Kicinski, M, Suciu, S & Robert, C 2020, ' Longer Follow-Up Confirms Recurrence-Free Survival Benefit of Adjuvant Pembrolizumab in High-Risk Stage III Melanoma: Updated Results From the EORTC 1325-MG/KEYNOTE-054 Trial ', Journal of Clinical Oncology, vol. 38, no. 33, pp. 3925-3936 . https://doi.org/10.1200/JCO.20.02110Test
Journal of Clinical Oncology, 38(33), 3925-3936. American Society of Clinical Oncology
Journal of Clinical Oncology
Eggermont, A M M, Blank, C U, Mandala, M, Long, G V, Atkinson, V G, Dalle, S, Haydon, A M, Meshcheryakov, A, Khattak, A, Carlino, M S, Sandhu, S, Larkin, J, Puig, S, Ascierto, P A, Rutkowski, P, Schadendorf, D, Koornstra, R, Hernandez-Aya, L, Di Giacomo, A M, van den Eertwegh, A J M, Grob, J J, Gutzmer, R, Jamal, R, Lorigan, P C, van Akkooi, A C J, Krepler, C, Ibrahim, N, Marreaud, S, Kicinski, M, Suciu, S & Robert, C 2020, ' Longer Follow-Up Confirms Recurrence-Free Survival Benefit of Adjuvant Pembrolizumab in High-Risk Stage III Melanoma : Updated Results From the EORTC 1325-MG/KEYNOTE-054 Trial ', Journal of clinical oncology : official journal of the American Society of Clinical Oncology, vol. 38, no. 33, pp. 3925-3936 . https://doi.org/10.1200/JCO.20.02110Test
Journal of Clinical Oncology, 38, 33, pp. 3925-3936

مصطلحات موضوعية: 0301 basic medicine, Oncology, Cancer Research, medicine.medical_specialty, medicine.medical_treatment, Medizin, Pembrolizumab, Placebo, law.invention, Cancer development and immune defence Radboud Institute for Health Sciences [Radboudumc 2], 03 medical and health sciences, All institutes and research themes of the Radboud University Medical Center, 0302 clinical medicine, Randomized controlled trial, law, Internal medicine, Original Reports, medicine, Stage III melanoma, Melanoma, Chemotherapy, Manchester Cancer Research Centre, business.industry, ResearchInstitutes_Networks_Beacons/mcrc, Cancer, medicine.disease, Clinical trial, 030104 developmental biology, 030220 oncology & carcinogenesis, business, Adjuvant

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::19c8d8800862ec580f808001677c9a85Test
https://hdl.handle.net/2066/228545Test

المؤلفون: Igle J. de Jong, Christian U. Blank, Thomas Powles, Roland Van Velthoven, Maureen J.B. Aarts, Michael A.S. Jewett, Sandrine Marreaud, Sandra Collette, Lori Wood, Sylvie Rottey, Harm H.E. van Melick, Peter F.A. Mulders, John B. A. G. Haanen, Axel Bex, Johannes V. Van Thienen, Jean Baptiste Lattouf, Bertrand Tombal, John Wagstaff, Laurence Collette, Roderick de Bruijn

المساهمون: UCL - SSS/IREC/CHEX - Pôle de chirgurgie expérimentale et transplantation, UCL - (SLuc) Service d'urologie, Interne Geneeskunde, MUMC+: MA Medische Oncologie (9), RS: GROW - R3 - Innovative Cancer Diagnostics & Therapy

المصدر: European Urology, Vol. 76, no. 4, p. 437-440 (2019)
European Urology, 76, 437-440
European Urology, 76(4), 437-440. ELSEVIER SCIENCE BV
European Urology, 76(4), 437-440. Elsevier
European Urology, 76, 4, pp. 437-440

مصطلحات موضوعية: medicine.medical_specialty, Urology, medicine.medical_treatment, 030232 urology & nephrology, PLANNED NEPHRECTOMY, urologic and male genital diseases, THERAPY, law.invention, 03 medical and health sciences, 0302 clinical medicine, Randomized controlled trial, RENAL-CELL CARCINOMA, Renal cell carcinoma, law, Cytoreductive nephrectomy, Urological cancers Radboud Institute for Molecular Life Sciences [Radboudumc 15], Medicine, Adverse effect, Surgical safety, business.industry, Sunitinib, Mortality rate, Retrospective cohort study, Common Terminology Criteria for Adverse Events, medicine.disease, EFFICACY, Nephrectomy, female genital diseases and pregnancy complications, Surgery, 030220 oncology & carcinogenesis, business, medicine.drug

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4b0e7e8b92600ad6a6b0194b11b05123Test
https://doi.org/10.1016/j.eururo.2019.06.006Test

المؤلفون: Michele W.L. Teng, Michael A. Postow, Reinhard Dummer, Claus Garbe, Paolo A. Ascierto, Christian U. Blank, Iman Osman, Michelle Krogsgaard, Patrick Hwu, Magdalena Thurin, Bernard A. Fox, Soldano Ferrone, Thomas F. Gajewski, Marc S. Ernstoff, Bart Neyns, Sergio A. Quezada, Igor Puzanov, Pawel Kalinski, Jason J. Luke, Roger S. Lo, Corrado Caracò, A. Testori, Giorgio Trinchieri

المساهمون: Clinical sciences, Medical Oncology, Laboratory of Molecular and Medical Oncology, University of Zurich, Ascierto, Paolo A

المصدر: Journal of Translational Medicine
Journal of Translational Medicine, Vol 19, Iss 1, Pp 1-18 (2021)

مصطلحات موضوعية: 0301 basic medicine, Oncology, BRAF inhibitor, medicine.medical_specialty, medicine.medical_treatment, 610 Medicine & health, Genetics and Molecular Biology, Translational research, Meeting Report, Anti-CTLA-4, Target therapy, General Biochemistry, Genetics and Molecular Biology, Targeted therapy, 03 medical and health sciences, 0302 clinical medicine, 1300 General Biochemistry, Genetics and Molecular Biology, Internal medicine, medicine, Melanoma, Adjuvant, Combination strategies, Tumor microenvironment, MEK inhibitor, business.industry, 10177 Dermatology Clinic, General Medicine, medicine.disease, Precision medicine, Immune checkpoint, Anti-PD-1, 030104 developmental biology, 030220 oncology & carcinogenesis, General Biochemistry, oncology, Biomarker (medicine), Medicine, Immunotherapy, Neoadjuvant, business, Biomarkers

وصف الملف: 910_Ascierto_PA._et_al._Perspectives_in_Melanoma_meeting_report_from_the_Melanoma_Bridge_(December_3rd-5th,_2020,_Italy)_J_Transl_Med_2021.pdf - application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::728ae34e331a3034551bf810df26f0f3Test
http://europepmc.org/articles/PMC8243582Test

المؤلفون: B.A. van de Wiel, Charlotte L. Zuur, Serigne Lo, Michel W.J.M. Wouters, Carolien Bierman, María Jesús González González, Elena Shklovskaya, Christian U. Blank, Willem M.C. Klop, Elisa A. Rozeman, Robert V. Rawson, J.B.A.G. Haanen, Omgo E. Nieweg, James S. Wilmott, Andrew J. Spillane, Robyn P. M. Saw, J.V. van Thienen, C. Adhikari, Sydney Ch'ng, A.C.J. van Akkooi, Michael T. Tetzlaff, Hanna Eriksson, Helen Rizos, Alexander Guminski, Richard A. Scolyer, Kerwin F. Shannon, W.J. van Houdt, Jonathan R. Stretch, Georgina V. Long, A.M. Menzies

المصدر: Annals of Oncology, 32(6), 766-777. ELSEVIER

مصطلحات موضوعية: 0301 basic medicine, Oncology, medicine.medical_specialty, Skin Neoplasms, medicine.medical_treatment, Ipilimumab, 03 medical and health sciences, 0302 clinical medicine, Fibrosis, Internal medicine, medicine, Humans, Melanoma, Pathological, Lymph node, business.industry, neoadjuvant, Reproducibility of Results, Hematology, Immunotherapy, medicine.disease, Neoadjuvant Therapy, 030104 developmental biology, medicine.anatomical_structure, 030220 oncology & carcinogenesis, Biomarker (medicine), immunotherapy, Nivolumab, business, pathological response, medicine.drug, metastatic melanoma

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ffb61a837c13200f2514a9ed7c1f22afTest
https://hdl.handle.net/1887/3276136Test